<div data-server-rendered="true" id="__nuxt"><div id="__layout"><div class="outer-container"><div class="content-container"> <div class="answer_container" style="min-height:calc(100vh - 54px);" data-v-0eba195e=""><div class="content_outer_container" data-v-0eba195e=""><div class="share_preview_container" data-v-0eba195e=""><div class="dialog_list" data-v-0eba195e=""><div class="dialog_item" data-v-0eba195e=""><div class="dialog_question fir_dialog_question" data-v-0eba195e=""><div class="question_con" data-v-0eba195e=""><h1 class="fir_question_content" data-v-0eba195e="">
                                    How did CPRX's Q4 2024 earnings surprise investors?
                                </h1> <div class="user_slot" data-v-0eba195e=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/default_aime_user.ec532c9.png" alt="user" class="avatar" data-v-0eba195e=""> <span class="user_desction" data-v-0eba195e="">
                                        
                                        4/4/2025 12:43am
                                    </span></div></div></div> <div class="seo-text-answer" data-v-0eba195e="">Catalyst Pharmaceuticals (CPRX) reported an earnings per share (EPS) surprise of $0.38 for the fourth quarter of 2024, compared to the consensus estimate. This positive surprise indicates that the company's performance exceeded market expectations, likely due to factors such as strong revenue growth, cost management, or strategic initiatives. Investors may react positively to this news, as it suggests that the company is performing well and may continue to do so in the future.

</div> <div class="dialog_answer" data-v-0eba195e=""><div class="dialog_content" data-v-0eba195e=""><div class="answer_content" data-v-0eba195e=""></div></div></div></div></div> </div></div></div> </div> <div class="extra-module" data-v-261d488f=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/recommend-logo.4f9ccc8.png" alt="right-logo" fetchpriority="high" class="recommend-logo-img" data-v-261d488f=""> <div class="recommend-part" data-v-7790c618="" data-v-261d488f=""><div class="recommend-query-card" data-v-8359219a="" data-v-7790c618=""><div class="title" data-v-8359219a=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/screener-recommend-icon.b007ca8.svg" alt="icon" data-v-8359219a=""> <span data-v-8359219a="">Aime finds your next big stock</span></div> </div> <div class="recommend-query-card" data-v-8359219a="" data-v-7790c618=""><div class="title" data-v-8359219a=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/stock-recommend-icon.77f1c78.svg" alt="icon" data-v-8359219a=""> <span data-v-8359219a="">Aime powers your decisions</span></div> </div></div> </div> <div class="container-mask" style="display:none;"></div></div></div></div><script>window.__NUXT__=(function(a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,A,B,C,D,E,F,G,H,I,J,K,L,M,N,O,P,Q,R,S,T,U,V,W,X,Y,Z,_,$,aa,ab,ac,ad,ae,af,ag,ah,ai,aj,ak,al,am,an,ao,ap,aq,ar,as,at,au,av,aw,ax,ay,az,aA,aB,aC,aD,aE,aF){return {layout:"default",data:[{noData:b,currentQuestion:g,textDescription:K,comeFrom:"AInvestShareLink",events:[],answerSource:n}],fetch:{},error:o,state:{sharePreviewModule:{loadJgySuccess:e,dialogRenderList:[{originAnswer:{input_media_info:[],session_round:i,agent_id:a,output_media_info:[],task_id:a,language:a,source:n,cache_builder:a,reply_action:"Answer",execute_mode:A,event_refresh_answer:a,param:"{\"entity_info\":{},\"add_info\":{\"ori_question\":\"How did CPRX's Q4 2024 earnings surprise investors?\"},\"event_list\":[],\"client_ip\":\"\",\"question\":\"How did CPRX's Q4 2024 earnings surprise investors?\",\"user_id\":\"dp49216433\",\"user_name\":\"\",\"trace_id\":\"936eda52-318f-4db4-80b9-f447be56406c\",\"session_id\":\"936eda52-318f-4db4-80b9-f447be56406c\",\"source\":\"ths_ainvest_lite_web\",\"input_type\":\"typewrite\"}",agent_info:[{info_type:"query_data",query_type:B,text:"1 results found:\n|stock code|stock name|Last Price|Last Change|EPS Surprise[20241231]|\n|---|---|---|---|---|\n|CPRX|Catalyst|$24.11|-1.43%|0.38|\n",query_data:{number:i,title:C,query_type:B,condition:a,model_sql:L,data_ext_params:{merge_repeat:b,expand_index:c,data_add:i,add_index:e}}}],answer_chain_name:M,agent_mode:N,native_answer:a,come_from:a,text_answer:K,trace_id:j,cost:11186,event_names:a,question:g,fallback_type:O,input_type:P,fall_back_reason:{fall_back_type:O,risk_detail:{matched_words:[]}},session_id:j,first_return_cost:2408,cache_type:a,question_id:j,transfer_question:g,signal_type:"ON_COMPLETE",start_time:Q,remote_svc:n,slots:[],answer_type:A,user_id:u,skill_name:D},renderList:[{type:"base_info",answer_path:"logs\u002FbaseInfo",logs:[],base_info:{trace_id:j,session_id:j,user_id:u,question:g,source:n,raw_question:g,version:"3.4.1",action_name:D,nlu:{entity:[{type:R,value:S,market:E}]},deep_research:b,deep_thinking:b,agent_mode:N},extra:{}},{answer_path:v,section:{id:w,info_texts:["Thinking"],show_type:x,choice:[],result_page:{},tag_info_list:[],is_last:c,status:"begin"},logs:[],extra:{is_deep_research:b,deep_thinking:b}},{answer_path:v,section:{id:w,info_texts:["Querying Stock: CPRX Earnings Surprise in Fiscal 2024 Q4"],show_type:x,choice:[],result_page:{},tag_info_list:[],is_last:c,status:"thinking"},logs:[],extra:{action:"Querying Stock",action_input:C,thought:"The user wants to know how CPRX's Q4 2024 earnings surprised investors. I should focus on the earnings surprise data for the quarter. I will use FinQuery for the data."}},{answer_path:d,section:{id:p,info_texts:[],show_type:k,choice:[],result_page:{},tag_info_list:[],is_last:c},logs:[],extra:{}},{answer_path:d,section:{id:p,info_texts:[],show_type:k,choice:[],result_page:{},tag_info_list:[],is_last:c},logs:[],extra:{}},{answer_path:v,section:{id:w,info_texts:["Generating Answer"],show_type:x,choice:[],result_page:{},tag_info_list:[],is_last:c,status:"ongoing"},logs:[],extra:{}},{answer_path:d,section:{id:l,info_texts:[],show_type:q,voice_txt:"C",text_answer:T,rich_text:T,choice:[],result_page:{},tag_info_list:[],is_last:c},logs:[],extra:{}},{answer_path:d,section:{id:2000,info_texts:[],show_type:q,voice_txt:a,text_answer:a,rich_text:a,choice:[],result_page:{},tag_info_list:[{title:C,query_type:B,trace_data:a,index:i,model_sql:L,data_ext_params:{merge_repeat:b,expand_index:c,data_add:i,add_index:e},jump_type:"data_query"}],is_last:c},logs:[],extra:{}},{answer_path:d,section:{id:l,info_texts:[],show_type:q,voice_txt:". This",text_answer:U,rich_text:U,choice:[],result_page:{},tag_info_list:[],is_last:c},logs:[],extra:{}},{answer_path:d,section:{id:1001,info_texts:[],show_type:"fenshi",choice:[],result_page:{},tag_info_list:[{stock_info:{code:V,market_id:E,name:W,domain:R},pos:e,section_id:l,txt:W,jump_type:"pos_fenshi"}],is_last:c},logs:[],extra:{}},{answer_path:d,section:{id:p,info_texts:[],show_type:k,choice:[],result_page:{},tag_info_list:[],is_last:c},logs:[],extra:{}},{answer_path:d,section:{id:p,info_texts:[],show_type:k,choice:[],result_page:{},tag_info_list:[],is_last:c},logs:[],extra:{}},{answer_path:d,section:{id:p,info_texts:[],show_type:k,choice:[],result_page:{},tag_info_list:[],is_last:c},logs:[],extra:{}},{answer_path:d,section:{id:l,info_texts:[],show_type:q,voice_txt:"\n",text_answer:X,rich_text:X,choice:[],result_page:{},tag_info_list:[],is_last:c},logs:[],extra:{}},{answer_path:d,section:{id:l,info_texts:[],show_type:Y,choice:[],result_page:{components:[{category:Z,puuid:_,request_config:[{related_name:$,source_type:F}],show_type:aa,tag:"Analyst Estimate Earnings",uuid:ab,title_config:{config:{display:b,display2:b,txt_style:e,type:ac,url:a},data:{h1:a,h2:a},show_type:ad}}],global:{interface_request_list:[],lowcode_json:{stack:b,visible:c,childLimit:ae,label:y,type:af,leaf:b,animate:[],version:ag,script:[],props:{test:a},path:ah,style:{"background-color":a,"box-shadow":ai,color:a,width:h,"min-height":aj,position:z,height:h},isMaterial:b,id:y,needTheme:b,hasEditor:b,packed:b,events:[],child:[{stack:b,visible:c,childLimit:e,label:"财报",type:ak,leaf:c,version:"0.0.1",animate:[],url:G,componentUuid:ab,script:[{name:"earnings",id:65539,content:"return {\r\n  mounted () {\r\n    window.__oversea_ainvest__ = {\r\n      ENV: \"production\"\r\n    }\r\n  }\r\n}"}],props:{title:"Earnings"},path:G,meta:{js_url:G},style:{"background-color":a,padding:"0",color:a,display:al,width:h,position:z,height:h},isMaterial:c,_id:am,id:ak,hasEditor:c,packed:b,events:[],isSetDefaultValue:c}]},lowcode_type:an,urp_static_data:[{name:$,value:{columns:[{index_name:ao,key:ao,type:f},{index_name:ap,key:ap,type:f}],dataSize:i,datas:[{code:V,market_code:E}]}},{name:"advance_custom_visual",value:{columns:[{index_name:aq,key:aq,type:f},{index_name:ar,key:ar,type:f},{index_name:as,key:as,type:f}],dataSize:i,datas:[{stock_code:S,start_date:"2024-01-01",end_date:"2024-12-31"}]}}]},page:{layout:{layout_data:"[{\"uuid\":\"gyyEarnings\",\"showType\":\"lowcode\",\"children\":[]}]"},render_for:H,uuid:_,voice_txt:a}},tag_info_list:[],is_last:b,uuid:"a8a51bca-e863-49a3-a730-5f5f3a40097a"},logs:[],extra:{}},{answer_path:d,section:{id:l,info_texts:[],show_type:q,voice_txt:a,text_answer:a,rich_text:a,choice:[],result_page:{},tag_info_list:[],is_last:c},logs:[],extra:{}},{answer_path:"extraInfo\u002FsourceLink",logs:[],extra:{span_id:a,link_id:a,source:a,link_text:a,link_param:a,link_ids:[]}},{answer_path:v,section:{id:w,info_texts:["Completed"],show_type:x,choice:[],result_page:{},tag_info_list:[],is_last:c,status:"end"},logs:[],extra:{}},{answer_path:"suggest\u002Fquestions",section:{id:10002,info_texts:[],show_type:Y,choice:[{display_text:r,query_text:r,trace_info:{item_id:"b406e7f58426f2562e6ec839ebd9afc0",item_type:m,item_name:r,rec_info:at}},{display_text:s,query_text:s,trace_info:{item_id:"91a74b4ce7d812379f07e4033fecf6b0",item_type:m,item_name:s,rec_info:au}},{display_text:t,query_text:t,trace_info:{item_id:"eedaf3c50acfb476d3a2a76eaa57b3f6",item_type:m,item_name:t,rec_info:av}}],result_page:{components:[{show_type:aa,title_config:{show_type:ad,data:{h1:a,h2:a},config:{display:b,txt_style:e,type:ac,display2:b,url:a}},request_config:[{source_type:F,related_name:aw}],puuid:I,tag:a,category:Z,uuid:ax}],global:{urp_static_data:[{name:aw,value:{status_code:e,columns:[{type:f,index_name:ay,key:ay},{type:f,index_name:az,key:az},{type:f,index_name:aA,key:aA},{type:f,index_name:aB,key:aB},{type:f,index_name:aC,key:aC}],datas:[{send_text:r,item_type:m,rec_info:at,display_text:r,rec_reason:a},{send_text:s,item_type:m,rec_info:au,display_text:s,rec_reason:a},{send_text:t,item_type:m,rec_info:av,display_text:t,rec_reason:a}],dataSize:F,status_msg:a}}],lowcode_type:an,interface_request_list:[],lowcode_json:{stack:b,visible:c,childLimit:ae,label:y,type:af,leaf:b,animate:[],version:ag,script:[],props:[],path:ah,isTransparent:c,style:{"background-color":a,"box-shadow":ai,color:a,width:h,"min-height":aj,position:z,height:h},isMaterial:b,id:y,needTheme:b,hasEditor:b,packed:b,events:[],child:[{readmeUrl:"https:",stack:b,visible:c,customStyle:a,childLimit:e,label:"路径推荐",type:"iwencai\u002FrecommendList",leaf:c,version:"1.12.0",animate:[],url:J,componentUuid:ax,script:[{name:aD,id:20240320,content:"return {\r\n  created: function created() {\r\n    this.isActive = !Boolean(this.$parent.$parent.$parent.$parent.$parent.$parent.question);\r\n    var showId ='tkPanel_bottomTag';\r\n  this.buryPointId = showId;\r\n  }\r\n};"}],props:{recommendList:[],isTransparent:c,renderType:"blue"},path:J,meta:{custom_editor_url:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Ffoiegras\u002FrecommendList\u002F1.12.0\u002FrecommendList@1.12.0editor.js",js_url:J},style:{"background-color":a,margin:"-12px 0px -12px 0px",color:a,display:al,width:h,position:z,height:h},isMaterial:c,_id:am,id:aD,hasEditor:c,packed:b,events:[],isSetDefaultValue:c}]}},page:{layout:{layout_data:"[{\"uuid\":\"ztxxx06c0a024223920bbbeb1e0926\",\"showType\":\"lowcode\",\"children\":[]}]"},render_for:H,voice_txt:a,tracking_info:{},uuid:I},order:{is_auto:b,render_for:H,chart_type:"command",puuid:I}},tag_info_list:[],is_last:c},logs:[],extra:{}},{answer_path:"suggest\u002Finputs",section:{id:10000,info_texts:[],show_type:"choice",choice:[],result_page:{},tag_info_list:[],is_last:c},logs:[],extra:{}},{answer_path:"logs\u002Ftrace_debug",section:{id:1005,info_texts:[],show_type:k,choice:[],result_page:{},tag_info_list:[],is_last:c},logs:[],extra:{action_name:D,with_paid_index:b,no_refresh_answer:b,answer_source:{agent_id:a,agent_name:a,execute_mode:A,answer_chain_name:M},is_deep_research:b,deep_thinking:b,create_time:1743741796152},is_last:c}],questionItem:{data:{qStr:g,encodeFlag:b,imageData:o,docsData:[],quoteData:o},tplType:"question"},events:aE,agentId:a,param:{entity_info:{},add_info:{ori_question:g},event_list:aE,client_ip:a,question:g,user_id:u,user_name:a,trace_id:j,session_id:j,source:n,input_type:P}}],userId:u,userName:a,startTime:Q,mobileType:a,comeFrom:a,textConstants:{},dialogContainer:o,endSignal:b,theme:"white",showTracePopup:b,traceListData:[],chatTraceTargetIndex:e,traceTableData:o,showMask:b}},serverRendered:c,routePath:"\u002Faime\u002Fshare\u002Fcprxs-q4-2024-earnings-surprise-investors-46a06a\u002F",config:{_app:{basePath:aF,assetsPath:aF,cdnURL:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Fiwc-aime-seo\u002F"}}}}("",false,true,"other\u002FopenAnswer",0,"STR","How did CPRX's Q4 2024 earnings surprise investors?","auto",1,"936eda52-318f-4db4-80b9-f447be56406c","signal",2001,"llm_generated","ths_ainvest_lite_web",null,999,"rich_text","📊 How did CPRX's Q4 2024 earnings impact its stock price?","📈 How did CPRX's Q4 2024 earnings compare to analyst expectations?","🔍 What are the current analyst ratings and target prices for CPRX?","dp49216433","progress\u002Fsearching_for",1000,"searching_for","root","relative","agent","intusstock","CPRX Earnings Surprise in Fiscal 2024 Q4","explain news events","186",3,"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Ffoiegras\u002Fearnings\u002F0.0.1\u002Fearnings@0.0.1index.js","aigc","39196","\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Ffoiegras\u002FrecommendList\u002F1.12.0\u002FrecommendList@1.12.0index.js","Catalyst Pharmaceuticals (CPRX) reported an earnings per share (EPS) surprise of $0.38 for the fourth quarter of 2024, compared to the consensus estimate. This positive surprise indicates that the company's performance exceeded market expectations, likely due to factors such as strong revenue growth, cost management, or strategic initiatives. Investors may react positively to this news, as it suggests that the company is performing well and may continue to do so in the future.\n\n","select   stock_code,   eps_surprise from   ustock_fin_forecast where   fiscal_date = date('2024y4q')   and stock_code = 'CPRX.O'","agent_common_v2\nagent-summary","normal_agent","NONE","typewrite",1743741784967,"stock","CPRX.O","Catalyst Pharmaceuticals (CPRX) reported an earnings per share (EPS) surprise of $0.38 for the fourth quarter of 2024, compared to the consensus estimate[^1]",". This positive surprise indicates that the company's performance exceeded market expectations, likely due to factors such as strong revenue growth, cost management, or strategic initiatives. Investors may react positively to this news, as it suggests that the company is performing well and may continue to do so in the future.\n\n","CPRX","Catalyst","\n``` visual\n{\"uuid\":\"a8a51bca-e863-49a3-a730-5f5f3a40097a\"}\n```","result_page","custom","39192","code_entity","lowcode","gyyEarnings","1","title1",9999,"thslc\u002Fthslc-common-container","1.0.1","\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Fkernel-thslc-resource\u002Fresource\u002Fainvest\u002F0Ae514cfA4\u002Fjs\u002F_thslc-common-container_1.0.1_index.js","0px 0px 0px","100%","iwencai\u002Fearnings","block",19,"shunda","market_code","code","stock_code","end_date","start_date","2+706_496_21_554+0+0+936eda52-318f-4db4-80b9-f447be56406c+b406e7f58426f2562e6ec839ebd9afc0+llm_generated+aimeTagAnalysis+0+0.07397429645061493+1","2+706_496_21_554+0+0+936eda52-318f-4db4-80b9-f447be56406c+91a74b4ce7d812379f07e4033fecf6b0+llm_generated+aimeTagAnalysis+0+0.05293742194771767+2","2+706_496_21_554+0+0+936eda52-318f-4db4-80b9-f447be56406c+eedaf3c50acfb476d3a2a76eaa57b3f6+llm_generated+aimeTagAnalysis+0+0.04563719034194946+3","recommend_query_list","ztxxx06c0a024223920bbbeb1e0926","send_text","item_type","rec_info","display_text","rec_reason","iwencai\u002FrecommendList0326",Array(0),"\u002F"));</script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/b929a16.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/28ccbec.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/d9802b5.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/2077034.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/1e0f8d6.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/7a5f495.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/921844b.js" defer=""></script>